StonvexLoading…
StonvexStonvexStonvexCore line items from HZO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.03B | $505.18M | $2.31B | $1.76B |
Operating Income | $15.76M | $4.92M | $34.02M | $20.17M |
Net Income | $-10.52M | $-7.93M | $-31.63M | $-30.78M |
EPS (Diluted) | $-0.48 | $-0.36 | $-1.43 | $-1.38 |
Total Assets | $2.44B | $2.43B | $2.47B | $2.49B |
Total Liabilities | $1.50B | $1.48B | $1.52B | $1.54B |
Cash & Equivalents | $189.13M | $164.60M | $170.35M | $151.02M |
Free Cash Flow OCF − CapEx | $52.84M | $8.34M | $11.94M | $-36.06M |
Shares Outstanding | 22.03M | 22.03M | 21.87M | 21.46M |